SYNTHETIC BIOLOGICS INC (SYN) Forecast, Price Target & Analyst Ratings

NYSEARCA:SYN • US87164U4094

Current stock price

1.02 USD
+0.01 (+0.99%)
At close:
1.1 USD
+0.08 (+7.84%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SYNTHETIC BIOLOGICS INC (SYN).

Forecast Snapshot

Consensus Price Target

Price Target
$6.12
+ 500.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 2, 2022
Period
Q3 / 2022
EPS Estimate
-$0.33
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.12
Upside
+ 500.00%
From current price of $1.02 to mean target of $6.12, Based on 6 analyst forecasts
Low
$4.04
Median
$6.12
High
$8.40

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for SYN. The average price target is 6.12 USD. This implies a price increase of 500% is expected in the next year compared to the current price of 1.02.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SYN Current Analyst RatingSYN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

SYN Historical Analyst RatingsSYN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4 5

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
SYN was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SYN.
In the previous month the buy percentage consensus was at a similar level.
SYN was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-03-12Maxim GroupUpgrade Hold -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 2, 2022
Period
Q3 / 2022
EPS Estimate
-$0.33
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-66.65%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

SYN is expected to report earnings on 11/2/2022. The consensus EPS estimate for the next earnings is -0.33 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
SYN revenue by date.SYN revenue by date.
N/AN/AN/AN/AN/A
EBITDA
YoY % growth
SYN ebitda by date.SYN ebitda by date.
-40.908M-39.095M
4.43%		-26.006M
33.48%		-17.299M
33.48%		-15.423M
10.84%		-9.959M
35.43%		-14.187M
-42.45%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
SYN ebit by date.SYN ebit by date.
-40.98M-39.252M
4.22%		-26.251M
33.12%		-17.571M
33.07%		-15.663M
10.86%		-10.16M
35.13%		-14.274M
-40.49%		N/A
-41.88%		N/A
-27.13%		N/A
-26.36%		N/A
27.47%		N/A
26.75%
Operating Margin
SYN operating margin by date.SYN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SYN eps by date.SYN eps by date.
-17.50-10.15
42.00%		-5.95
41.38%		-3.00
49.58%		-2.64
12.00%		-6.10
-131.06%		-2.10
65.57%		N/A
38.44%		N/A
-12.11%		N/A
26.83%		N/A
-6.30%		N/A
-7.36%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.33
-66.65%		-0.34
15.41%		-0.30
-1.00%		-0.30
2.26%		-0.33-0.31
7.46%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-5.352M
-63.43%		-5.57M
-5.80%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SYN Yearly EPS VS EstimatesSYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.34%
EPS Next 5 Year
7.32%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SYNTHETIC BIOLOGICS INC / SYN Forecast FAQ

Can you provide the average price target for SYNTHETIC BIOLOGICS INC stock?

6 analysts have analysed SYN and the average price target is 6.12 USD. This implies a price increase of 500% is expected in the next year compared to the current price of 1.02.

When does SYNTHETIC BIOLOGICS INC (SYN) report earnings?

SYNTHETIC BIOLOGICS INC (SYN) will report earnings on 2022-11-02, after the market close.

What are the consensus estimates for SYN stock next earnings?

The consensus EPS estimate for the next earnings of SYNTHETIC BIOLOGICS INC (SYN) is -0.33 USD and the consensus revenue estimate is 0 USD.

How do analysts rate SYNTHETIC BIOLOGICS INC (SYN)?

The consensus rating for SYNTHETIC BIOLOGICS INC (SYN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.